UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Application of New Cholesterol Guidelines to a Population-Based Sample

The New England journal of medicine, 2014-04, Vol.370 (15), p.1422-1431

2014

Volltextzugriff (PDF)

The Severe Hypercholesterolemia Phenotype

Journal of the American College of Cardiology, 2014-05, Vol.63 (19), p.1935-1947

2014

Volltextzugriff (PDF)

Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease

Circulation (New York, N.Y.), 2015-02, Vol.131 (5), p.451-458

2015

Volltextzugriff (PDF)

Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk

Journal of the American Heart Association, 2022-10, Vol.11 (20), p.e025858

2022

Volltextzugriff (PDF)

A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk

Circulation Cardiovascular quality and outcomes, 2011-05, Vol.4 (3), p.337-345

2011

Volltextzugriff (PDF)

Discordance analysis of Apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study

Atherosclerosis, 2012-12, Vol.225 (2), p.444-449

2012

Volltextzugriff (PDF)

Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding

Journal of lipid research, 2018-07, Vol.59 (7), p.1266-1275

2018

Volltextzugriff (PDF)

Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels

International journal of molecular sciences, 2022-08, Vol.23 (16), p.9417

2022

Volltextzugriff (PDF)

Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in Women

Clinical chemistry (Baltimore, Md.), 2017-04, Vol.63 (4), p.870-879

2017

Volltextzugriff (PDF)

The Necessity for Clinical Reasoning in the Era of Evidence-Based Medicine

Mayo Clinic proceedings, 2013-10, Vol.88 (10), p.1108-1114

2013

Volltextzugriff (PDF)

Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoB

Current opinion in lipidology, 2014-12, Vol.25 (6), p.461-467

2014

Volltextzugriff (PDF)

Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol

Journal of the American Heart Association, 2023-08, Vol.12 (15), p.e030405-e030405

2023

Volltextzugriff (PDF)

Are Triglyceride-Rich Lipoprotein ApoB Particles Really 4 Times More Atherogenic Than LDL ApoB Particles?

Journal of the American College of Cardiology, 2024-10, Vol.84 (14), p.1339-1341

Sniderman, Allan D.

2024

Volltextzugriff (PDF)

ApoB vs non-HDL-C vs LDL-C as Markers of Cardiovascular Disease

Clinical chemistry (Baltimore, Md.), 2021-11, Vol.67 (11), p.1440-1442

Sniderman, Allan D

2021

Volltextzugriff (PDF)

Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis-Brief Report

Arteriosclerosis, thrombosis, and vascular biology, 2016-12, Vol.36 (12), p.2421-2423

2016

Volltextzugriff (PDF)

The Severe Hypercholesterolemia Phenotype: Clinical Diagnosis, Management, and Emerging Therapies

Journal of the American College of Cardiology, 2014-05, Vol.63 (19), p.1935-1947

2014

Volltextzugriff (PDF)

Age as a modifiable risk factor for cardiovascular disease

The Lancet (British edition), 2008-05, Vol.371 (9623), p.1547-1549

2008

Volltextzugriff (PDF)

dal-GenE was negative-not positive except for COVID-19

European heart journal, 2022-12, Vol.43 (48), p.5061-5061

Sniderman, Allan D

2022

Volltextzugriff (PDF)

Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-The Framingham Heart Study

Journal of the American Heart Association, 2020-09, Vol.9 (18), p.e014711

2020

Volltextzugriff (PDF)

Key Questions About Familial Hypercholesterolemia: JACC Review Topic of the Week

Journal of the American College of Cardiology, 2022-03, Vol.79 (10), p.1023-1031

2022

Volltextzugriff (PDF)

Peculiar Paradoxical Results That Puzzle Me

Journal of the American College of Cardiology, 2021-04, Vol.77 (13), p.1698-1699

Sniderman, Allan D

2021

Volltextzugriff (PDF)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol

Journal of the American Heart Association, 2016-10, Vol.5 (10), p.n/a

2016

Volltextzugriff (PDF)

Type III Hyperlipoproteinemia: The Forgotten, Disregarded, Neglected, Overlooked, Ignored but Highly Atherogenic, and Highly Treatable Dyslipoproteinemia

Clinical chemistry (Baltimore, Md.), 2019-02, Vol.65 (2), p.225-227

Sniderman, Allan D

2019

Volltextzugriff (PDF)

Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects

The journal of clinical endocrinology and metabolism, 2003-04, Vol.88 (4), p.1594-1602

2003

Volltextzugriff (PDF)

Apolipoprotein B versus non-high-density lipoprotein cholesterol: contradictory results in the same journal

European journal of preventive cardiology, 2022-12, Vol.29 (18), p.2347-2348

Sniderman, Allan D

2022

Volltextzugriff (PDF)

1 – 25 von 313

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(305)
Mit Volltextzugriff
(240)

Publikationsform

Artikel
(312)
Buchkapitel
(1)

Sprache

Englisch
(313)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Application of New Cholesterol Guidelines to a Population-Based Sample

The Severe Hypercholesterolemia Phenotype

Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease

Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk

A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk

Discordance analysis of Apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study

Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding

Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels

Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in Women

The Necessity for Clinical Reasoning in the Era of Evidence-Based Medicine

Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoB

Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol

Are Triglyceride-Rich Lipoprotein ApoB Particles Really 4 Times More Atherogenic Than LDL ApoB Particles?

ApoB vs non-HDL-C vs LDL-C as Markers of Cardiovascular Disease

Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis-Brief Report

The Severe Hypercholesterolemia Phenotype: Clinical Diagnosis, Management, and Emerging Therapies

Age as a modifiable risk factor for cardiovascular disease

dal-GenE was negative-not positive except for COVID-19

Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-The Framingham Heart Study

Key Questions About Familial Hypercholesterolemia: JACC Review Topic of the Week

Peculiar Paradoxical Results That Puzzle Me

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol

Type III Hyperlipoproteinemia: The Forgotten, Disregarded, Neglected, Overlooked, Ignored but Highly Atherogenic, and Highly Treatable Dyslipoproteinemia

Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects

Apolipoprotein B versus non-high-density lipoprotein cholesterol: contradictory results in the same journal

Suchergebnisse filtern